8 completed, 1 unknown, 1 withdrawn. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 8, Unknown 1, Withdrawn 1 |
Follow aclidinium bromide: new trials by email Literature Review of aclidinium bromide trials Research Report on aclidinium bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease Aclidinium bromide/formoterol fumarate combination, Standard of Care - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | AstraZeneca | 2017-12-04 | 2017-07-02 | |
| The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours. Tiotropium 'Respimat' 5 mcg, Aclidinium Bromide/Formoterol Fumarate 340/12 mcg - Chronic Obstructive Airway Disease | Phase 4 | Unknown | Maastricht University Medical Center | 49 | 2017-07-07 | 2020-03-10 |
| Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial Budesonide & formoterol fumarate and Aclidinium bromide, Fluticasone 500 & salmeterol and Aclidinium bromide, Fluticasone 250 & salmeterol and Aclidinium bromide - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | University of Dundee | 158 | 2016-12-01 | 2020-07-20 |
| Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease ACL/FOR, Placebo - COPD | Phase 4 | Completed | Queen's University | 40 | 2015-10-01 | 2019-07-12 |
| Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients Aclidinium/Formoterol, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | AstraZeneca | 267 | 2015-04-27 | 2018-10-09 |
| BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH Aclidinium Bromide, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | AstraZeneca | 300 | 2015-03-01 | 2017-04-21 |
| Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients Aclidinium Bromide, Glycopyrronium Bromide - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | University of Milan | 37 | 2014-06-01 | 2014-10-29 |
| A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) Aclidinium bromide, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | AstraZeneca | 30 | 2014-04-01 | 2016-11-09 |
| Evaluation of Long-Acting Muscarinic Antagonists in COPD Tiotropium, Aclidinium - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | University of Dundee | 15 | 2014-02-01 | 2019-04-12 |
| Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. Aclidinium Bromide, Placebo - COPD, Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | AstraZeneca | 3635 | 2013-10-16 | 2018-12-06 |
Pulmonary Disease, Chronic Obstructive (10) · Motor Activity (1) · Sleep Initiation and Maintenance Disorders (1)
AstraZeneca (5) · University of Dundee (2) · Maastricht University Medical Center (1) · Queen's University (1) · University of Milan (1)
Canada (3) · Germany (3) · United Kingdom (3) · Hungary (2) · Italy (2) · Spain (2) · Netherlands (1) · United States (1)
Anna Ribera (1) · Anna Ribera, PhD (1) · Arvind Deva Manoharan, MBChB (1) · Brina Lipworth, MD (1) · Denis E O'Donnell, MD, FRCPC (1) · James Chalmers, MBChB, MRCP (1) · Kenneth R. Chapman, MD MSc FRCPC FACP FCCP (1) · Lowie Vanfleteren, MD, PhD (1) · Pierachille Santus, MD, PhD (1) · Robert Wise, MD (1)
PMID 26549785, PMID 26758884, PMID 28642315, PMID 31063575, PMID 32603714, PMID 33776428, PMID 34528220, PMID 34686204, PMID 35034195, PMID 35342289
2014 (2), 2016 (1)